TY - JOUR
T1 - Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle
AU - Shimizu, Noriaki
AU - Yoshikawa, Noritada
AU - Ito, Naoki
AU - Maruyama, Takako
AU - Suzuki, Yuko
AU - Takeda, Sin Ichi
AU - Nakae, Jun
AU - Tagata, Yusuke
AU - Nishitani, Shinobu
AU - Takehana, Kenji
AU - Sano, Motoaki
AU - Fukuda, Keiichi
AU - Suematsu, Makoto
AU - Morimoto, Chikao
AU - Tanaka, Hirotoshi
N1 - Funding Information:
This work was supported by Grants-in-Aid for Scientific Research, (to H.T., N.S., and N.Y.) and by grants from the Ministry of Health, Labour, and Welfare and from Japan Science and Technology Agency, Japan (to H.T.). Y.T., S.N., and K.T. are employees of Ajinomoto Pharmaceutical Company.
PY - 2011/2/2
Y1 - 2011/2/2
N2 - Maintenance of skeletal muscle mass relies on the dynamic balance between anabolic and catabolic processes and is important for motility, systemic energy homeostasis, and viability. We identified direct target genes of the glucocorticoid receptor (GR) in skeletal muscle, i.e., REDD1 and KLF15. As well as REDD1, KLF15 inhibits mTOR activity, but via a distinct mechanism involving BCAT2 gene activation. Moreover, KLF15 upregulates the expression of the E3 ubiquitin ligases atrogin-1 and MuRF1 genes and negatively modulates myofiber size. Thus, GR is a liaison involving a variety of downstream molecular cascades toward muscle atrophy. Notably, mTOR activation inhibits GR transcription function and efficiently counteracts the catabolic processes provoked by glucocorticoids. This mutually exclusive crosstalk between GR and mTOR, a highly coordinated interaction between the catabolic hormone signal and the anabolic machinery, may be a rational mechanism for fine-tuning of muscle volume and a potential therapeutic target for muscle wasting.
AB - Maintenance of skeletal muscle mass relies on the dynamic balance between anabolic and catabolic processes and is important for motility, systemic energy homeostasis, and viability. We identified direct target genes of the glucocorticoid receptor (GR) in skeletal muscle, i.e., REDD1 and KLF15. As well as REDD1, KLF15 inhibits mTOR activity, but via a distinct mechanism involving BCAT2 gene activation. Moreover, KLF15 upregulates the expression of the E3 ubiquitin ligases atrogin-1 and MuRF1 genes and negatively modulates myofiber size. Thus, GR is a liaison involving a variety of downstream molecular cascades toward muscle atrophy. Notably, mTOR activation inhibits GR transcription function and efficiently counteracts the catabolic processes provoked by glucocorticoids. This mutually exclusive crosstalk between GR and mTOR, a highly coordinated interaction between the catabolic hormone signal and the anabolic machinery, may be a rational mechanism for fine-tuning of muscle volume and a potential therapeutic target for muscle wasting.
UR - http://www.scopus.com/inward/record.url?scp=79551559572&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79551559572&partnerID=8YFLogxK
U2 - 10.1016/j.cmet.2011.01.001
DO - 10.1016/j.cmet.2011.01.001
M3 - Article
C2 - 21284984
AN - SCOPUS:79551559572
SN - 1550-4131
VL - 13
SP - 170
EP - 182
JO - Cell Metabolism
JF - Cell Metabolism
IS - 2
ER -